EKSO insiders were on both sides of the trade this year. Buys came to roughly $1.2 million (three buyers), sales to $232,000 (three sellers).
Biggest single buyer: ASHER DANIEL, 10% Owner, with roughly $292,000. That includes C-suite money, which tends to get the most attention.
Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Jones Jason C | COO | Buy | 1,308 | $11.85 | $15K | SEC |
| Mar 20, 2026 | Wong Jerome | CFO | Buy | 1,308 | $11.85 | $15K | SEC |
| Feb 20, 2026 | ASHER DANIEL | 10% Owner | Buy | 15,540 | $12.30 | $191K | SEC |
| Feb 19, 2026 | ASHER DANIEL | 10% Owner | Buy | 1,200 | $9.60 | $12K | SEC |
| Feb 17, 2026 | ASHER DANIEL | 10% Owner | Buy | 16,100 | $8.96 | $144K | SEC |
| Feb 17, 2026 | ASHER DANIEL | 10% Owner | Buy | 11,092 | $9.14 | $101K | SEC |
| Feb 17, 2026 | ASHER DANIEL | 10% Owner | Buy | 8,908 | $9.18 | $82K | SEC |
| Feb 17, 2026 | ASHER DANIEL | 10% Owner | Buy | 20,611 | $9.69 | $200K | SEC |
| Feb 17, 2026 | ASHER DANIEL | 10% Owner | Buy | 10,200 | $9.92 | $101K | SEC |
| Feb 17, 2026 | ASHER DANIEL | 10% Owner | Buy | 4,800 | $9.96 | $48K | SEC |
| Feb 17, 2026 | ASHER DANIEL | 10% Owner | Buy | 194 | $9.86 | $2K | SEC |
| Feb 17, 2026 | ASHER DANIEL | 10% Owner | Buy | 30,124 | $9.69 | $292K | SEC |
| Jan 7, 2026 | Jones Jason C | COO | Sell | 1,320 | $9.25 | $12K | SEC |
| Dec 10, 2025 | Jones Jason C | COO | Sell | 270 | $4.70 | $1K | SEC |
| Dec 10, 2025 | Wong Jerome | CFO | Sell | 1,238 | $4.70 | $6K | SEC |
In the last 12 months Ekso Bionics Holdings, Inc. insiders made open-market purchases worth about $1.2 million and sales worth about $232,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in EKSO was filed on 2026-03-20.
No congressional trades in EKSO were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).